Cinven is reviewing strategic options for laboratory-services company Synlab International GmbH including a potential sale, people with knowledge of the matter said.
The private equity firm has been speaking with potential advisers and could start a sale process early next year, the people said, asking not to be identified because the information is private. Cinven plans to seek a valuation of about 5.5 billion euros ($6 billion) including debt for Augsburg, Germany-based Synlab, one of the people said.
A sale of Synlab would likely attract other private equity firms, the people said. No final decision has been made, and Cinven could elect to keep the business, the people said. A spokeswoman for Cinven declined to comment, while Synlab didn’t answer phone calls seeking comment.
Cinven first invested in Synlab in June 2015, buying a majority stake from fellow private equity firm BC Partners for about 1.7 billion euros, Bloomberg News reported at the time. It combined the business with Labco SA, which it agreed to buy earlier that year for 1.2 billion euros.
Synlab, led by Chief Executive Officer Mathieu Floreani, also counts Novo A/S and Ontario Teachers’ Pension Plan as minority investors, according to its website. It operates across more than 40 countries, handling more than 500 million clinical tests annually, according to Synlab’s website.
Cinven also owns stakes in retailer Kurt Geiger and German drugmaker Stada Arzneimittel AG, according to its website.
The sale plan comes at a time when Cinven’s rival Apax Partners is also weighing a sale of diagnostic services business Unilabs. The buyout firm is working with advisers at Rothschild & Co. to look at options for the business, people familiar with the matter said last week.
Source: Bloomberg
Can’t stop reading? Read more
Eldridge targets $1bn for new GP-solutions fund amid private equity liquidity crunch
Eldridge targets $1bn for new GP-solutions fund amid private equity liquidity crunch Eldridge Capital Management is aiming to raise $1bn for a new GP-solutions fund as private equity firms increasingly seek alternative financing to manage liquidity pressures,...
Canada Goose attracts $1.4bn take-private offers as Bain explores exit
Canada Goose attracts $1.4bn take-private offers as Bain explores exit Bain Capital has received bids to take luxury apparel maker Canada Goose private in a deal valuing the company at about $1.4bn, according to CNBC. The private equity firm, which first invested in...
Japan private equity take-privates set to exceed $40bn as firms embrace delistings
Japan private equity take-privates set to exceed $40bn as firms embrace delistings Private equity-led take-private deals in Japan are on course to exceed last year’s $40.3bn record as listed companies increasingly pursue buyouts under pressure from activist investors...